Rchr
J-GLOBAL ID:201401059428138050   Update date: Oct. 24, 2024

Takahashi Masanobu

タカハシ マサノブ | Takahashi Masanobu
Affiliation and department:
Job title: Associate Professor
Homepage URL  (1): http://www.co.idac.tohoku.ac.jp/
Research field  (1): Tumor diagnostics and therapeutics
Research keywords  (1): Clinical Oncology
Research theme for competitive and other funds  (8):
  • 2021 - 2024 Identification of alterations in non-coding RNA and development of novel therapeutic strategy for BRAF-mutated colorectal cancer
  • 2019 - 2022 Research on pathogenesis of DNA-highly methylated type colorectal cancer and the development of diagnosis and treatment methods
  • 2018 - 2021 Analysis of non-coding RNA involved in tumorigenesis of colorectal cancer with poor prognosis, and discovery of novel therapy using non-coding-RNA-related mechanism
  • 2015 - 2018 Functional analysis of small RNAs involved in tumorigenesis of a new molecular subtype of colorectal cancer, and investigation of their new molecular targets
  • 2015 - 2018 Study on anti-EGFR antibody-resistant conquest of high DNA methylation type colorectal cancer
Show all
Papers (96):
  • Hiroo Imai, Yasuhiro Sakamoto, Shin Takahashi, Hiroyuki Shibata, Atsushi Sato, Kazunori Otsuka, Kenji Amagai, Masanobu Takahashi, Takuhiro Yamaguchi, Chikashi Ishioka. Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201). BMC cancer. 2024. 24. 1. 262-262
  • Sakura Hiraide Taniguchi, Keigo Komine, Noriko Takenaga, Yuya Yoshida, Keiju Sasaki, Yoshifumi Kawamura, Yuki Kasahara, Kota Ouchi, Hiroo Imai, Ken Saijo, et al. FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma. Anticancer research. 2023. 43. 12. 5699-5704
  • Hiroo Imai, Ken Saijo, Yoshifumi Kawamura, Shuto Kodera, Keigo Komine, Tomoyuki Iwasaki, Noriko Takenaga, Yuki Kasahara, Kota Ouchi, Hidekazu Shirota, et al. Comparison of efficacy and safety between carboplatin-etoposide and cisplatin-etoposide combination therapy in patients with advanced neuroendocrine carcinoma, retrospective study. Oncology. 2023
  • Reio Ueta, Hiroo Imai, Ken Saijo, Yoshifumi Kawamura, Shuto Kodera, Keigo Komine, Kota Ouchi, Yuki Kasahara, Sakura Taniguchi, Yuya Yoshida, et al. Antibiotics May Interfere with Nivolumab Efficacy in Patients with Head and Neck Squamous Cell Carcinoma. Oncology. 2023. 1-8
  • Shonosuke Wakayama, Kota Ouchi, Shin Takahashi, Yasuhide Yamada, Yoshito Komatsu, Ken Shimada, Tatsuro Yamaguchi, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka. TP53 Gain-of-Function Mutation is a Poor Prognostic Factor in High-Methylated Metastatic Colorectal Cancer. Clinical colorectal cancer. 2023
more...
MISC (123):
  • 小峰啓吾, 高橋雅信, 高橋雅信, 岩崎智行, 岩崎智行, 大内康太, 吉田裕也, 吉田裕也, 沼倉龍之助, 沼倉龍之助, et al. Efficacy and safety of DOAC for treatments of VTE in patients undergoing cancer drug treatment. 日本臨床腫瘍学会学術集会(CD-ROM). 2023. 20th
  • 若山祥之介, 若山祥之介, 斎藤里佳, 斎藤里佳, 大内康太, 大内康太, 丹内啓允, 渡邊裕文, 小寺修仁, 小寺修仁, et al. 皮下埋込型中心静脈ポート造設手技中にガイドワイヤーがキアリ網に捕捉された一例. 日本腫瘍循環器学会学術集会抄録集(Web). 2023. 6th
  • Sakura Hiraide, Keigo Komine, Masanobu Takahashi, Chikashi Ishioka. Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”. International Journal of Clinical Oncology. 2021. 26. 3. 621
  • Keigo Komine, Masanobu Takahashi, Sakura Hiraide, Hideharu Yamada, Mari Tsubata, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Tetsuya Niihori, Yoko Aoki, et al. Adoption of multigene panel testing for hereditary cancer "CancerNext" in Tohoku University Hospital. ANNALS OF ONCOLOGY. 2019. 30
  • Keigo Komine, Masanobu Takahashi, Sakura Hiraide, Sho Umegaki, Yoshifumi Kawamura, Hideharu Yamada, Akira Okita, Sonoko Chikamatsu, Yuki Kasahara, Yoshinari Okada, et al. Three cases of venous thromboembolism in advanced cancer patients. ANNALS OF ONCOLOGY. 2018. 29. 8-8
more...
Lectures and oral presentations  (9):
  • CVD療法を施行し病勢進行を抑制することができた悪性褐色細胞腫の2例
    (第6回日本臨床腫瘍学会 2008)
  • 当科におけるBevacizumab+FOLFOX4療法施行の症例の検討
    (第6回日本臨床腫瘍学会 2008)
  • 切除不能再発胆道癌・胆管細胞癌に対してGemcitabineを使用した15例の検討
    (第6回日本臨床腫瘍学会 2008)
  • 5FU系単独療法から多剤併用療法へとシフトアップした進行・再発大腸癌症例の検討
    (第6回日本臨床腫瘍学会 2008)
  • 当科におけるBevacizumab+FOLFOX4療法施行症例の検討
    (第41回制癌剤適応研究会 2008)
more...
Education (2):
  • - 2006 Tohoku University Graduate School, Division of Medicine
  • - 1999 Tohoku University Faculty of Medicine
Professional career (1):
  • 博士(医学) (Tohoku University)
Work history (5):
  • 2017/04 - 現在 IDAC, Tohoku University Department of Clinical Oncology Associate Professor
  • 2014/04 - 2017/03 Tohoku University Hospital University Hospital Clinical Oncology Lecturer
  • 2012/04 - 2014/03 Tohoku University Hospital University Hospital Clinical Oncology Assistant Professor
  • 2009/09 - 2012/03 Baylor University Medical Center Gastrointestinal Cancer Research Laboratory Postdoctoral fellow
  • 2007/10 - 2009/08 Tohoku University Hospital University Hospital Clinical Oncology Assistant Professor
Association Membership(s) (7):
European Society for Medical Oncology ,  American Society of Clinical Oncology ,  American Association for Cancer Research ,  日本臨床腫瘍学会(2004/01-) ,  日本癌治療学会(2002/04-) ,  日本癌学会(2002/04-) ,  日本内科学会(1999/04-)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page